Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-23-065902

Chief Commercial Officer acquired 7,834 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Huntsman Carole Chief Commercial Officer 2023-11-20 Grant or award +7,834 7,834 D
Derivatives
Huntsman Carole Chief Commercial Officer 2023-11-20 Grant or award · Stock Option (Right to Buy) +10,077 10,077 D
Loading xslF345X05/ownership.xml…